Philip Morton

Chief Technology Officer • Albumedix

Philip Morton has a strong technology background with over 25 years of experience in the biopharmaceutical industry, working across process and product development, and product application research. As the Chief Technology Officer of Albumedix, Dr Morton leads a team of specialists to refine recombinant albumin technologies and harness the multifaceted protein that is albumin. 


Also speaking

Antonin de Fougerolles

Chief Executive Officer • Evox Therapeutics

Ben Weil

Director of Manufacturing  • INmune Bio

John Garcia

PhD, Head of New Manufacturing Technologies • UCL

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.